BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6272470)

  • 1. Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer.
    Saiers JH; Slavik M
    Vet Hum Toxicol; 1981; 23(Suppl 1):12-4. PubMed ID: 6272470
    [No Abstract]   [Full Text] [Related]  

  • 2. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
    Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
    Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
    [No Abstract]   [Full Text] [Related]  

  • 3. "Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial".
    Holoye PY
    Cancer Treat Rep; 1987 Apr; 71(4):431-2. PubMed ID: 3030548
    [No Abstract]   [Full Text] [Related]  

  • 4. Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
    Loehrer PJ; Birch R; Kramer BS; Greco FA; Einhorn LH
    Cancer Treat Rep; 1986 Jul; 70(7):919-20. PubMed ID: 3013402
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ifosfamide in the treatment of small cell carcinoma of the lung].
    Mukouda K; Morikawa E; Hasegawa K; Noumi K; Ohmura T; Mishima Y; Kawamoto M; Inagaki A; Kamitsuna A; Yamakido M; Nishimoto Y; Koyama T; Katsuta S
    Gan To Kagaku Ryoho; 1983 May; 10(5):1293-8. PubMed ID: 6307164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-drug combination chemotherapy in extensive non-small cell lung cancer: a Southwest Oncology Group Pilot Study.
    Livingston RB; Mira J; O'Bryan RM
    Cancer Treat Rep; 1981; 65(1-2):143-4. PubMed ID: 6164484
    [No Abstract]   [Full Text] [Related]  

  • 7. The bioavailability of oral and intravenous ifosfamide in the treatment of bronchogenic carcinoma.
    McNiel NO; Morgan LR
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):490-3. PubMed ID: 7298241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifosfamide in the treatment of extensive non-oat cell carcinoma of the lung.
    Costanzi JJ; Morgan LR; Hokanson J
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):61-5. PubMed ID: 6298945
    [No Abstract]   [Full Text] [Related]  

  • 9. Ifosfamide vs cyclophosphamide in cancer therapy.
    Weiss RB
    Oncology (Williston Park); 1991 May; 5(5):67-76; discussion 76-82, 84-6. PubMed ID: 1653004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose ifosfamide: efficacy studies in non-small cell lung cancer.
    Harrison EF; Hawke JE; Hunter HL; Costanzi JJ; Morgan LR; Plotkin D; Tucker WG; Worrall PM
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):56-60. PubMed ID: 6298944
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin and polychemotherapy for treatment of lung cancer.
    Rohwedder JJ; Sagastume E
    Cancer Treat Rep; 1977 Oct; 61(7):1399-401. PubMed ID: 589603
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of patients with lung cancer with a combination of nitrosomethylurea and cyclophosphane].
    Perevodchikova NI; Korman NP; Bychkov MB
    Vopr Onkol; 1975; 21(8):21-5. PubMed ID: 170742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of ambulatory infusional delivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE).
    Lokich J; Anderson N; Moore C; Bern M; Coco F; Dow E
    J Infus Chemother; 1996; 6(1):39-42. PubMed ID: 8748006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical study of acetylcysteine's preventing ifosfamide-induced hematuria.
    Slavik M; Saiers JH
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):62-5. PubMed ID: 6836328
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of oat cell metastazing bronchial carcinoma with isofosfamide. Results of a prospective randomized study].
    Kokron O
    Osterr Z Onkol; 1974; (5-6):123-7. PubMed ID: 4377798
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J; Saiz GarcĂ­a F
    Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate in the chemotherapy of lung cancer.
    Smyth JF; Ford HT
    Cancer Treat Rep; 1981; 65 Suppl 1():161-3. PubMed ID: 6275986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for lung cancer.
    Perevodchikova NI
    Cancer Treat Rep; 1976 Oct; 60(10):1479-81. PubMed ID: 191187
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of the effectiveness of N-nitrosomethylurea and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea combined with cyclophosphane in inoperable lung cancer].
    Assekritova IV; Perevodchikova NI; Batinov IN; Bychkov MB; Vaarik KhM
    Vestn Akad Med Nauk SSSR; 1978; (9):87-90. PubMed ID: 214971
    [No Abstract]   [Full Text] [Related]  

  • 20. Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer.
    Gemma A; Kudoh S; Yoshimura A; Ono Y; Takenaka K; Hayashihara K; Hino M; Shibuya M; Niitani H
    Anticancer Res; 1995; 15(6B):2691-5. PubMed ID: 8669849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.